Condition: Amyotrophic Lateral Sclerosis · Sponsor: Merit E. Cudkowicz, MD
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| Mayo Clinic Scottsdale | Scottsdale, Arizona, United States | — |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| UC San Diego | La Jolla, California, United States | — |
| Loma Linda University Health | Loma Linda, California, United States | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | — |
| University of Southern California | Los Angeles, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| University of California, Irvine | Orange, California, United States | — |
| Forbes Norris MDA/ALS Research Center, California Pacific Medical Center | San Francisco, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| University of Colorado | Aurora, Colorado, United States | — |
+ 69 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.